Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss itself improves fertility outcomes in people with obesity, yet concerns about GLP-1 medications and reproductive health persist. Current clinical evidence suggests that GLP-1 receptor agonists do not directly impair fertility, though hormonal changes during rapid weight loss may temporarily affect menstrual cycles. Understanding the real risks versus myths can help you make informed decisions about treatment.

How GLP-1 Medications Work and Their Effect on Hormones

GLP-1 receptor agonists like semaglutide activate natural appetite-control pathways in the brain and pancreas. These medications slow gastric emptying and increase feelings of fullness, leading to reduced calorie intake and weight loss. Unlike hormonal birth control or fertility medications, GLP-1 drugs do not directly alter reproductive hormone production or ovarian function.

Weight loss itself triggers changes in hormone levels, including shifts in estrogen, insulin, and leptin. These hormonal fluctuations are reversible and typically reflect the body's adaptation to a leaner mass, not damage to reproductive organs. When weight stabilizes on GLP-1 therapy, hormone levels usually normalize, and most people experience improved metabolic health overall.

Does GLP-1 Impact Menstrual Cycles and Ovulation?

Some patients report irregular periods or temporary changes in cycle length during the first few months of GLP-1 therapy. These changes are primarily driven by rapid weight loss, which can affect the hormonal signals that regulate the menstrual cycle. Notably, the disruption is not caused by the medication itself but by the body's response to decreased fat mass and improved insulin sensitivity.

Research indicates that menstrual irregularities during weight loss therapy are temporary and resolve once weight stabilizes. Studies in people using GLP-1 medications have not documented lasting effects on ovulation or fertility capacity. In fact, weight loss often restores regular cycles in people with obesity-related irregular periods, potentially improving fertility prospects.

Pregnancy Safety and GLP-1 Treatment Timing

GLP-1 medications are not recommended during pregnancy because safety data in pregnant individuals remains limited. Most clinical guidelines suggest discontinuing GLP-1 therapy when pregnancy is confirmed or planned. However, achieving a healthy weight before conception significantly reduces risks of gestational diabetes, preeclampsia, and cesarean delivery.

If you are planning pregnancy, discuss timing with your healthcare provider before starting GLP-1 treatment. Many patients successfully use semaglutide or tirzepatide to reach a target weight, then pause therapy before conception. PlexusDx works with qualified medical providers who can coordinate your GLP-1 schedule with family planning goals, ensuring safe and informed decisions.

Weight Loss Benefits for Reproductive Health and Fertility

Obesity significantly increases infertility risk in people of all reproductive ages through insulin resistance, chronic inflammation, and hormonal imbalance. Studies show that even a 5-10% weight reduction can restore ovulation, improve sperm quality, and enhance fertility outcomes. GLP-1 medications facilitate the sustained weight loss needed to unlock these reproductive health benefits.

People who achieve substantial weight loss on GLP-1 therapy often report restored menstrual regularity, improved energy for physical activity, and greater confidence in family planning. The fertility advantage of reaching a healthier weight typically outweighs temporary cycle changes during the weight loss phase. PlexusDx patients can combine semaglutide injection ($149/month) or other GLP-1 options with personalized medical support to optimize both metabolic and reproductive outcomes.

Genetic Factors and Individual Responses to GLP-1 Therapy

Not everyone responds to GLP-1 medications identically; genetic variations influence medication efficacy, weight loss speed, and hormonal adaptation. PlexusDx Precision Peptide Genetic Test identifies key variants in the GLP1R, GIPR, FTO, and MC4R genes that predict how your body processes GLP-1 signals and regulates hunger and metabolism. Understanding your genetic profile enables your provider to select the most effective GLP-1 compound and dose strategy for your body.

Personalized testing also reveals individual predispositions to metabolic traits that affect fertility, such as insulin resistance or fat distribution patterns. By matching medication choice to your genetics, PlexusDx helps maximize weight loss efficiency and minimize the time your body experiences hormonal fluctuation. The $99 Precision Peptide Genetic Test (available after your first month of treatment) maps 14 pathways and 150+ genetic insights specific to peptide metabolism.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will GLP-1 medications prevent me from getting pregnant?

No. GLP-1 medications do not impair fertility or ovulation capacity. However, they should be discontinued when pregnancy is planned or confirmed. Weight loss achieved on GLP-1 therapy often improves fertility by reducing insulin resistance and restoring hormonal balance, making pregnancy more likely once you reach a target weight and pause the medication.

Is it normal to have irregular periods on GLP-1 therapy?

Yes, temporary menstrual irregularities can occur during rapid weight loss on GLP-1 medications. This is caused by shifts in hormone levels as your body adapts to lower fat mass, not by damage to reproductive organs. Periods typically regulate once weight loss plateaus and your body stabilizes at a new baseline.

What does the clinical evidence say about GLP-1 and reproductive outcomes?

Clinical trials and real-world data show no direct negative impact of GLP-1 agonists on fertility, menstrual function, or pregnancy success rates. Studies consistently demonstrate that weight loss—the primary effect of GLP-1 therapy—improves fertility outcomes by reducing insulin resistance, lowering inflammation, and restoring regular ovulation in people with obesity-related infertility.

How much does semaglutide cost at PlexusDx, and is it affordable?

PlexusDx compounded semaglutide injection starts at $149 per month with no flat per-compound pricing increases—your dose may increase over time, but your monthly cost won't. The medication is HSA/FSA eligible, requires no insurance or membership, and is available across all 50 states from licensed 503A compounding pharmacies.

Can the Precision Peptide Genetic Test help predict my response to GLP-1 and fertility outcomes?

Yes. PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 therapy and regulates metabolism and weight. For $99 (available after your first treatment month), this test maps 14 pathways and 150+ genetic insights to help optimize your medication choice and predict weight loss speed, which directly affects the timeline and severity of hormonal changes during treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves